BR0014150A - Diagnósticos e terapêuticos para osteoporose - Google Patents

Diagnósticos e terapêuticos para osteoporose

Info

Publication number
BR0014150A
BR0014150A BR0014150-0A BR0014150A BR0014150A BR 0014150 A BR0014150 A BR 0014150A BR 0014150 A BR0014150 A BR 0014150A BR 0014150 A BR0014150 A BR 0014150A
Authority
BR
Brazil
Prior art keywords
osteoporosis
therapeutics
diagnostics
diagnoses
therapies
Prior art date
Application number
BR0014150-0A
Other languages
English (en)
Inventor
Simon Van Dijk
Gordonw Duff
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of BR0014150A publication Critical patent/BR0014150A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "DIAGNóSTICOS E TERAPêUTICOS PARA OSTEOPOROSE". Diagnósticos e terapêuticas para osteoporose, os quais são baseados na identificação do padrão de haplótipo de IL-1 do indivíduo estão descritos.
BR0014150-0A 1999-08-30 2000-08-30 Diagnósticos e terapêuticos para osteoporose BR0014150A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15146099P 1999-08-30 1999-08-30
PCT/US2000/023844 WO2001016377A2 (en) 1999-08-30 2000-08-30 Diagnostics and therapeutics for osteoporosis

Publications (1)

Publication Number Publication Date
BR0014150A true BR0014150A (pt) 2002-05-14

Family

ID=22538869

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014150-0A BR0014150A (pt) 1999-08-30 2000-08-30 Diagnósticos e terapêuticos para osteoporose

Country Status (11)

Country Link
US (2) US6558905B1 (pt)
EP (1) EP1212464B1 (pt)
JP (1) JP2004504802A (pt)
AT (1) ATE318328T1 (pt)
AU (2) AU785040B2 (pt)
BR (1) BR0014150A (pt)
CA (1) CA2382848C (pt)
DE (1) DE60026150T2 (pt)
ES (1) ES2261239T3 (pt)
MX (1) MXPA02002251A (pt)
WO (1) WO2001016377A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784224B2 (en) * 1999-06-30 2006-02-23 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
KR20040026665A (ko) * 2001-06-15 2004-03-31 인터레우킨 제네틱스, 인코포레이티드 노화 관련 증상의 조기 개시를 검출 및 치료하는 방법
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
JP2005529585A (ja) * 2002-01-25 2005-10-06 インターリューキン ジェネティックス インコーポレイテッド Ｉｌ−１遺伝子群ならびに関連する炎症性多型およびハプロタイプ
AU2003265676A1 (en) * 2002-08-24 2004-03-11 Creighton University Methods for detecting genes associated with bone properties and/or height
EP1585838A2 (en) * 2003-01-16 2005-10-19 Decode Genetics EHF. Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association
ATE490339T1 (de) 2003-08-08 2010-12-15 Interleukin Genetics Inc Diagnostikum für osteoporose
US8590329B2 (en) 2004-12-22 2013-11-26 Johnson Controls Technology Company Medium voltage power controller
US7353662B2 (en) * 2004-12-22 2008-04-08 York International Corporation Medium voltage starter for a chiller unit
EP1951903A2 (en) * 2005-10-25 2008-08-06 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
WO2008060627A2 (en) * 2006-11-15 2008-05-22 Interleukin Genetics, Inc. The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
AU2017207341A1 (en) 2016-01-12 2018-08-02 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
WO2020245402A1 (en) 2019-06-06 2020-12-10 Cardioforecast Ltd Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
DK0652975T3 (da) 1992-07-31 2005-02-14 Garvan Inst Med Res Vurdering af allelvariation med hensyn til trans-virkende faktorer
CA2152667C (en) 1992-12-28 2003-02-11 David J. Baylink Bone resorption assay
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
EP1212464A2 (en) 2002-06-12
MXPA02002251A (es) 2003-08-20
CA2382848A1 (en) 2001-03-08
US6558905B1 (en) 2003-05-06
WO2001016377A3 (en) 2002-01-17
DE60026150T2 (de) 2006-11-16
EP1212464B1 (en) 2006-02-22
AU7338000A (en) 2001-03-26
AU785040B2 (en) 2006-08-31
CA2382848C (en) 2011-01-04
AU2006203097A1 (en) 2006-08-17
ES2261239T3 (es) 2006-11-16
ATE318328T1 (de) 2006-03-15
WO2001016377A2 (en) 2001-03-08
US20040110168A1 (en) 2004-06-10
DE60026150D1 (de) 2006-04-27
JP2004504802A (ja) 2004-02-19
AU2006203097B2 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
BR9802806B1 (pt) máquina universal para análises clìnicas.
HK1093757A1 (en) Diagnostic for osteoporosis
WO2002085285A3 (en) Methods and reagents for regulating bone and cartilage formation
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
DE69732309D1 (de) Primerzusammensetzungen für den Dentalbereich
BR0206364A (pt) Métodos para tratar doenças auto-imunes em um indivìduo e testes diagnósticos in vitro
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
NO20035732L (no) Diagnostiske analyser for parvovirus B19
DE60322848D1 (de) System für kontinuierliche leistungstests
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
WO2000034511A3 (de) Peptid screening test zum nachweis von ass
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
ATE369429T1 (de) Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
DE69933833D1 (de) Ultraschall-Diagnosesystem
DE69718146D1 (de) At1 rezeptor antagonist zur anregung von apoptosis
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
WO2002072883A3 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
NZ514691A (en) Method to type prion proteins
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE374260T1 (de) Asthma-assoziiertes gen
ATE364180T1 (de) Screeningverfahren mit bnpi und dnpi

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]